Literature DB >> 9435641

Epinephrine inhibits endotoxin-induced IL-1 beta production: roles of tumor necrosis factor-alpha and IL-10.

T Van der Poll1, S F Lowry.   

Abstract

Epinephrine has been found to inhibit the production of the proinflammatory cytokine tumor necrosis factor (TNF)-alpha and to enhance the production of anti-inflammatory cytokine interleukin (IL)-10. To determine the effect of epinephrine on IL-1 beta production, the following experiments were performed: 1) blood obtained from subjects at 4-21 h after the start of a continuous infusion of epinephrine (30 ng.kg-1.min-1) produced less IL-1 beta after ex vivo stimulation with lipopolysaccharide (LPS), compared with blood drawn from subjects infused with saline; 2) in whole blood in vitro, epinephrine caused a dose-dependent decrease in LPS-induced IL-1 beta production, which was likely mediated via adrenergic receptors; and 3) inhibition of TNF and enhancement of IL-10 both contributed to epinephrine-induced inhibition of IL-1 beta production. Epinephrine, either endogenously produced or administered as a component of sepsis treatment, may attenuate excessive activity of proinflammatory cytokines early in the course of systemic infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9435641     DOI: 10.1152/ajpregu.1997.273.6.R1885

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  32 in total

Review 1.  Anti-TNF antibody treatment of Crohn's disease.

Authors:  S J van Deventer
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Sepsis-induced immunosuppression: from bad to worse.

Authors:  R C Reddy; G H Chen; P K Tekchandani; T J Standiford
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 3.  Present concepts on the inflammatory modulators with special reference to cytokines.

Authors:  A S J P A M Van Miert
Journal:  Vet Res Commun       Date:  2002-02       Impact factor: 2.459

Review 4.  On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies.

Authors:  Carolina Muscoli; Salvatore Cuzzocrea; Dennis P Riley; Jay L Zweier; Christoph Thiemermann; Zhi-Qiang Wang; Daniela Salvemini
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

5.  Pro-inflammatory responses in human monocytes are beta1-adrenergic receptor subtype dependent.

Authors:  Laurel A Grisanti; Janel Evanson; Erica Marchus; Heather Jorissen; Andrew P Woster; Wanda DeKrey; Edward R Sauter; Colin K Combs; James E Porter
Journal:  Mol Immunol       Date:  2010-01-29       Impact factor: 4.407

6.  Acute stress elicited by bungee jumping suppresses human innate immunity.

Authors:  David J van Westerloo; Goda Choi; Ester C Löwenberg; Jasper Truijen; Alex F de Vos; Erik Endert; Joost C M Meijers; Lu Zhou; Manuel P F L Pereira; Karla C S Queiroz; Sander H Diks; Marcel Levi; Maikel P Peppelenbosch; Tom van der Poll
Journal:  Mol Med       Date:  2010-12-10       Impact factor: 6.354

Review 7.  Psychological stress in IBD: new insights into pathogenic and therapeutic implications.

Authors:  J E Mawdsley; D S Rampton
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

8.  Gender differences in stimulated cytokine production following acute psychological stress.

Authors:  Aric A Prather; Judith E Carroll; Jacqueline M Fury; Kevin K McDade; Diana Ross; Anna L Marsland
Journal:  Brain Behav Immun       Date:  2008-12-06       Impact factor: 7.217

9.  Metastatic-promoting effects of LPS: sexual dimorphism and mediation by catecholamines and prostaglandins.

Authors:  Ranit Naor; Vered Domankevich; Shaily Shemer; Luba Sominsky; Ella Rosenne; Ben Levi; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2008-10-08       Impact factor: 7.217

10.  In vivo endotoxin synchronizes and suppresses clock gene expression in human peripheral blood leukocytes.

Authors:  Beatrice Haimovich; Jacqueline Calvano; Adrian D Haimovich; Steve E Calvano; Susette M Coyle; Stephen F Lowry
Journal:  Crit Care Med       Date:  2010-03       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.